COVID-19 Impact on Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Small Interfering RNA (siRNA) Therapeutics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Liposome Based Systemic Therapy
  • 1.4.3 Nanoparticle Based Systemic Therapy
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Research Institutions
  • 1.5.4 Pharmaceutical and Biotechnology Companies
  • 1.5.5 Academic Institutions
  • 1.5.6 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Small Interfering RNA (siRNA) Therapeutics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Small Interfering RNA (siRNA) Therapeutics Industry
    • 1.6.1.1 Small Interfering RNA (siRNA) Therapeutics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Small Interfering RNA (siRNA) Therapeutics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Small Interfering RNA (siRNA) Therapeutics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Small Interfering RNA (siRNA) Therapeutics Market Perspective (2015-2026)
• 2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
  • 2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Small Interfering RNA (siRNA) Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Small Interfering RNA (siRNA) Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Small Interfering RNA (siRNA) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Market Size
  • 3.1.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio
  • 3.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Therapeutics Revenue in 2019
• 3.3 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
• 3.5 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
• 6.2 Small Interfering RNA (siRNA) Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
• 7.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
• 8.2 Small Interfering RNA (siRNA) Therapeutics Key Players in China (2019-2020)
• 8.3 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
• 8.4 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
• 9.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
• 10.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
• 11.2 Small Interfering RNA (siRNA) Therapeutics Key Players in India (2019-2020)
• 11.3 India Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
• 11.4 India Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
• 12.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 GE
  • 13.1.1 GE Company Details
  • 13.1.2 GE Business Overview and Its Total Revenue
  • 13.1.3 GE Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020))
  • 13.1.5 GE Recent Development
• 13.2 Horizon Discovery
  • 13.2.1 Horizon Discovery Company Details
  • 13.2.2 Horizon Discovery Business Overview and Its Total Revenue
  • 13.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.2.5 Horizon Discovery Recent Development
• 13.3 Thermo Scientific
  • 13.3.1 Thermo Scientific Company Details
  • 13.3.2 Thermo Scientific Business Overview and Its Total Revenue
  • 13.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.3.5 Thermo Scientific Recent Development
• 13.4 OPKO Health
  • 13.4.1 OPKO Health Company Details
  • 13.4.2 OPKO Health Business Overview and Its Total Revenue
  • 13.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.4.5 OPKO Health Recent Development
• 13.5 AInylam Pharmaceuticals
  • 13.5.1 AInylam Pharmaceuticals Company Details
  • 13.5.2 AInylam Pharmaceuticals Business Overview and Its Total Revenue
  • 13.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.5.5 AInylam Pharmaceuticals Recent Development
• 13.6 Arrowhead Research
  • 13.6.1 Arrowhead Research Company Details
  • 13.6.2 Arrowhead Research Business Overview and Its Total Revenue
  • 13.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.6.5 Arrowhead Research Recent Development
• 13.7 Sanofi Genzyme
  • 13.7.1 Sanofi Genzyme Company Details
  • 13.7.2 Sanofi Genzyme Business Overview and Its Total Revenue
  • 13.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.7.5 Sanofi Genzyme Recent Development
• 13.8 Genecon Biotechnologies
  • 13.8.1 Genecon Biotechnologies Company Details
  • 13.8.2 Genecon Biotechnologies Business Overview and Its Total Revenue
  • 13.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.8.5 Genecon Biotechnologies Recent Development
• 13.9 Arbutus Biopharma
  • 13.9.1 Arbutus Biopharma Company Details
  • 13.9.2 Arbutus Biopharma Business Overview and Its Total Revenue
  • 13.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.9.5 Arbutus Biopharma Recent Development
• 13.10 Silent Therapeutics
  • 13.10.1 Silent Therapeutics Company Details
  • 13.10.2 Silent Therapeutics Business Overview and Its Total Revenue
  • 13.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Introduction
  • 13.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 13.10.5 Silent Therapeutics Recent Development
• 13.11 Sylentis
  • 10.11.1 Sylentis Company Details
  • 10.11.2 Sylentis Business Overview and Its Total Revenue
  • 10.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Introduction
  • 10.11.4 Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
  • 10.11.5 Sylentis Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer